Latigo Biotherapeutics Inc.
NASDAQ:LTGOMedical - Pharmaceuticals
+$0.76 today
- Market cap
- $800.64M
- Beta
- 0.00
Volume 0.21M
Average 0.38M
LTGO Other Current Liabilities
Short-term obligations not reported separately, such as accrued expenses.
Other Current Liabilities history
Currency unavailable · from the balance sheet
No Other Current Liabilities data reported for this period type.
Other Current Liabilities vs competitors
How LTGO compares with its peers on the latest reported figures
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
| Mar 2026 | $393.4M USD | +1196.2% | +531.1% | 23.8% | |
| Mar 2026 | $308.06M USD | +70394.3% | +945.6% | 104.9% | |
| Mar 2026 | $59.15M USD | — | +54.0% | 4.9% | |
LTGOLatigo Biotherapeutics Inc. | — | — | — | — | — |
| Peer median (excluding LTGO) | — | +35795.2% | +531.1% | 23.8% | |
Competitors are the stored peer set for LTGO. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Latigo Biotherapeutics Inc.
NASDAQ:LTGO
Intrinsic Alpha fair value
Locked
Current Price
$13.31
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.